[Results of the use of the drug Superlymph in the treatment of chronic cystitis according to clinical studies].

About 30 million cases of urinary tract infections (UTI) are registered annually in the Russian Federation. An important feature of UTI is the tendency for their recurrent course, which significantly worsens the quality of life of patients. In addition, it increases the number of cases of temporary disability, which determines the socio-economic significance of UTI. Normalization of the human immune status plays an important role in the prevention of relapses of chronic diseases. Superlymph is a natural complex of natural antimicrobial peptides and cytokines, which are universal stimulants of the immune system secreted by leukocytes of the peripheral blood of pigs. In addition to the immunomodulatory effect, Superlymph has antiviral, antimicrobial and fungicidal properties. A review of data from 7 clinical studies of the use of Superlymph in patients with chronic cystitis with a total number of more than 800 participants is presented in the article. The results demonstrated that the drug Superlymph allows to relieve more effectively symptoms of exacerbations of chronic cystitis, increases the duration of the relapse-free period, improves microcirculation of the urethra and vagina, and reduces the severity of inflammation in the bladder.